Dhawan, Sangeeta
Natarajan, Rama
Funding for this research was provided by:
National Institutes of Health (UC4 DK104162, R01 grant DK120523)
Article History
First Online: 27 June 2019
Compliance With Ethical Standards
:
: Sangeeta Dhawan declares no conflict of interest.Rama Natarajan reports a pending patent on inhibitors of epigenetically modified targets.
: All the studies noted in this review that were performed by the authors involving animals were done in compliance with appropriate institutional committees for animal research (IACUC), and all institutional guidelines for the care and use of animals were followed. Studies quoted in this article undertaken by the authors involving human subjects were either carried out on retrospective deidentified samples obtained from appropriate repositories, in compliance with institutional review boards (IRB), or all the procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review boards (IRB), and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.